F13.288
Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder
Clinical Classification Guidelines
Inclusion Terms
- Sedative, hypnotic, or anxiolytic use disorder, moderate, with sedative, hypnotic, or anxiolytic-induced mild neurocognitive disorder
- Sedative, hypnotic, or anxiolytic use disorder, severe, with sedative, hypnotic, or anxiolytic-induced mild neurocognitive disorder
Medical Intelligence & Overview
ICD-10 code F13.288 describes a condition where a person has developed a dependence on sedative, hypnotic, or anxiolytic medications and is also experiencing additional mental or cognitive issues caused by these drugs. These medications are often prescribed for anxiety, sleep disorders, or related conditions, but misuse or dependence can lead to serious health challenges. This guide offers an overview of this complex disorder, its causes, symptoms, diagnosis, and treatments, presented in an accessible manner for patients and caregivers.
Causes & Symptoms
Clinical Causes: Prolonged use or misuse of sedative, hypnotic, or anxiolytic medications Inadequate medical supervision during ongoing medication use Underlying mental health conditions like anxiety or insomnia leading to continued medication use Development of tolerance, requiring higher doses for the same effect Genetic predisposition to substance dependence History of substance abuse or dependence
Key Symptoms: Dependence on sedative, hypnotic, or anxiolytic medications, characterized by compulsive use Difficulty stopping or reducing medication intake despite negative effects Development of tolerance requiring increased doses Withdrawal symptoms upon stopping or reducing medication, such as anxiety, agitation, or sleep disturbances Cognitive impairments, including memory problems or decreased concentration Mood swings or emotional instability Physical symptoms like tremors or sweating during withdrawal Impaired social, occupational, or daily functioning Additional mental health issues related to neurocognitive disturbance, such as mild difficulties in thinking or reasoning
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive medical and psychological assessment. Healthcare professionals evaluate medication history, symptoms of dependence and neurocognitive changes, and conduct mental status examinations. They may use specific criteria outlined in psychiatric diagnostic manuals to confirm the presence of a sedative, hypnotic, or anxiolytic use disorder with induced neurocognitive disorder. Laboratory tests, including blood or urine screens, can help detect medication levels and rule out other causes of symptoms.
Treatment Protocols: Treatment strategies focus on managing dependence and addressing cognitive or mental health issues. Typical approaches include: - Tapering medications carefully under medical supervision to reduce dependence - Psychotherapy, such as cognitive-behavioral therapy, to address underlying mental health concerns and develop healthier coping mechanisms - Support groups for substance dependence - Medical management of withdrawal symptoms - Cognitive rehabilitation exercises if neurocognitive disturbances are present - Monitoring for the potential of relapse and ongoing support Effective treatment is often multidisciplinary, involving medical, psychological, and social support to ensure safety and promote recovery.
Clinical Advice & FAQs
Billing Guidance
Is F13.288 a billable ICD-10 code?
Yes, F13.288 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.288?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference